This is a medicine that combines two different drugs, ezetimibe and simvastatin. Both drugs help lower high cholesterol levels in your blood. It's used to treat high cholesterol and high triglycerides, which can increase your risk of heart problems.
Every report comes from a Lived member, sent anonymously.
Have you tried Vytorin (Ezetimibe-Simvastatin) for High Cholesterol (Hypercholesterolemia)?
Vytorin is a prescription tablet that combines two cholesterol-lowering medicines: ezetimibe and simvastatin, a statin. It is also sold as generic ezetimibe and simvastatin. Along with a heart-healthy diet, it is used to lower LDL (low-density lipoprotein) cholesterol, often called "bad" cholesterol because it builds up in artery walls and raises the risk of heart attack and stroke. It is approved for adults with high cholesterol and for adults and children 10 and older with heterozygous familial hypercholesterolemia, an inherited condition that causes very high LDL from birth. Adults with the rarer and more severe homozygous form may take it alongside other cholesterol treatments. Simvastatin on its own is proven to lower the risk of heart attack, stroke and death in people at high risk of heart disease. Whether adding ezetimibe prevents more of these events is less settled. The US label says an extra benefit beyond simvastatin alone has not been established. A large trial in people recently hospitalized for a heart attack or unstable chest pain found that the combination lowered LDL further and modestly reduced later heart and stroke events compared with simvastatin alone. In a separate trial of people with moderate to severe chronic kidney disease, it reduced major heart and blood vessel events compared with a placebo, though it did not slow kidney decline.
The cholesterol in your blood comes from two places: what the liver makes and what the gut absorbs from food and bile. Each ingredient blocks one of these sources. Simvastatin slows an enzyme the liver needs to make cholesterol. Ezetimibe blocks a transporter in the small intestine that absorbs cholesterol. With less cholesterol arriving from either route, the liver pulls more LDL out of the bloodstream. Together they lower LDL more than the same dose of simvastatin alone. In one 12-week study, the combination lowered LDL by about half on average, compared with about 40 percent for simvastatin alone.
Vytorin is taken by mouth once a day in the evening, with or without food. Each strength lists the ezetimibe dose first and the simvastatin dose second: the ezetimibe dose is always 10 mg, and the simvastatin dose is 10, 20, 40 or 80 mg. The usual range is 10/10 to 10/40 mg. The 10/80 mg strength is restricted to people who have already taken it for a year or more without muscle problems, because the 80 mg simvastatin dose carries a higher risk of muscle injury. People who need a stronger statin, or who do not reach their LDL goal on 10/40 mg, are usually switched to a different treatment rather than moved to the highest dose. Certain heart medicines set a lower maximum dose, and in moderate to severe kidney disease, doses above 10/20 mg are used cautiously with closer monitoring. If you also take a bile acid binder such as cholestyramine, take Vytorin at least 2 hours before or 4 hours after it. If you miss a dose, take it as soon as you remember, but do not double the next one.
In studies, the most common side effects were headache, muscle aches, diarrhea and cold-like symptoms. Blood tests sometimes show a rise in liver enzymes, which usually causes no symptoms and often settles on its own. Statins, including the simvastatin in Vytorin, can also nudge blood sugar up slightly, so people with or at risk of diabetes may see small changes in their glucose or HbA1c (a measure of average blood sugar). The most important serious risk is muscle damage. In rare cases it becomes rhabdomyolysis, a breakdown of muscle that can harm the kidneys. Contact your prescriber promptly about unexplained muscle pain, tenderness or weakness, especially with fever or feeling generally unwell. The risk is higher at age 65 and over, with kidney disease or an underactive thyroid that is not controlled, at the 80 mg simvastatin dose, and with certain other medicines. Serious liver injury is rare. Contact your prescriber promptly about unusual tiredness, loss of appetite, pain in the upper right abdomen, dark urine or yellowing of the skin or eyes.
Simvastatin is broken down by the liver through a pathway that many other medicines block, which can raise simvastatin levels and the risk of muscle damage. Vytorin must not be combined with strong blockers of this pathway, including the antifungals itraconazole and ketoconazole, the antibiotics clarithromycin and erythromycin, some HIV and hepatitis C medicines, and nefazodone, an antidepressant. It also must not be taken with cyclosporine (a transplant and immune-suppressing drug), danazol (a hormone medicine) or gemfibrozil (a triglyceride-lowering drug). If a short course of one of these antifungals or antibiotics is unavoidable, Vytorin is usually paused. Other medicines mean a lower Vytorin dose rather than avoidance. These include the heart rhythm drugs amiodarone and dronedarone, the blood pressure and heart drugs verapamil, diltiazem and amlodipine, and ranolazine, a chest pain medicine. Colchicine (a gout medicine), niacin (vitamin B3) in the high doses sometimes prescribed for cholesterol, and fenofibrate, another triglyceride-lowering drug from the same family as gemfibrozil, can add to muscle risk. People taking warfarin need their INR (a blood clotting test) checked when Vytorin is started or changed. Avoid grapefruit juice, which raises simvastatin levels. Tell any clinician who prescribes a new medicine that you take Vytorin. Vytorin should not be used by people with acute liver failure or advanced cirrhosis that has begun causing complications such as fluid buildup in the belly or yellowing of the skin. Heavy alcohol use or a history of liver disease raises the risk of liver problems. Stop Vytorin and contact your prescriber if you become pregnant, as it may harm a developing baby; lowering cholesterol can usually wait until after pregnancy. Breastfeeding is not recommended while taking it.
Most of the LDL-lowering effect is in place within about two weeks of starting. Your prescriber may recheck your cholesterol as early as four weeks in and adjust the plan if needed. Liver tests may be checked before starting and later if there is a reason. You will not feel cholesterol coming down, so blood tests are the way to see that it is working; the hoped-for payoff, fewer heart attacks and strokes, builds over years. The benefit lasts only while you keep taking it, so for most people it is a long-term medicine taken alongside diet, activity and other heart-risk care. If side effects or cost are a problem, talk with your prescriber about alternatives rather than stopping on your own. If you are admitted to hospital for a serious infection, major surgery or another severe illness, your team may pause Vytorin for a while, because those situations raise the risk of muscle breakdown affecting the kidneys.
Last reviewed • Oct 2026
Educational content, not medical advice.
Share your experience taking Vytorin (Ezetimibe-Simvastatin), what you've noticed, or ask the community a question.